Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPYM
3726
State Street SPDR Portfolio S&P 500 ETF
SPYM
$171B
| $1.55M | ﹤0.01% |
30,898
+7,255
| +31% | +$380K |
|
3727
Ligand Pharmaceuticals
LGND
$5.59B
| $1.55M | ﹤0.01% |
+25,886
| New | +$1.7M |
|
|
VBTX
3728
DELISTED
Veritex Holdings
VBTX
| $1.55M | ﹤0.01% |
86,349
-23,886
| -22% | -$461K |
|
3729
Mercantile Bank Corp
MBWM
$1.04B
| $1.55M | ﹤0.01% |
50,105
+14,838
| +42% | +$485K |
|
3730
Bluerock Homes Trust
BHM
$35.4M
| $1.55M | ﹤0.01% |
119,802
-4,693
| -4% | -$70.1K |
|
3731
Invesco S&P 500 Quality ETF
SPHQ
$19.6B
| $1.54M | ﹤0.01% |
30,852
+25,752
| +505% | +$1.32M |
|
3732
iShares Core S&P US Value ETF
IUSV
$28B
| $1.54M | ﹤0.01% |
20,672
+13,038
| +171% | +$1.02M |
|
|
SRCL
3733
DELISTED
Stericycle Inc
SRCL
| $1.54M | ﹤0.01% |
34,484
-118,484
| -77% | -$5.29M |
|
3734
PUT
Alnylam Pharmaceuticals
ALNY
$31.7B
| $1.54M | ﹤0.01% |
8,700
-56,500
| -87% | -$10.8M |
|
3735
CALL
Ginkgo Bioworks
DNA
$469M
| $1.54M | ﹤0.01% |
+21,250
| New | +$1.7M |
|
3736
Carlyle Secured Lending
CGBD
$811M
| $1.54M | ﹤0.01% |
106,018
+76,333
| +257% | +$1.14M |
|
3737
PUT
Xenon Pharmaceuticals
XENE
$5.81B
| $1.54M | ﹤0.01% |
+45,000
| New | +$1.68M |
|
3738
PUT
Huntington Ingalls Industries
HII
$11.6B
| $1.53M | ﹤0.01% |
7,500
| – | – |
|
3739
BlackBerry
BB
$4.78B
| $1.53M | ﹤0.01% |
323,323
-143,731
| -31% | -$706K |
|
3740
Pacira BioSciences
PCRX
$1.03B
| $1.53M | ﹤0.01% |
49,921
+42,147
| +542% | +$1.52M |
|
3741
iShares 0-5 Year TIPS Bond ETF
STIP
$16B
| $1.53M | ﹤0.01% |
15,779
+11,640
| +281% | +$1.13M |
|
3742
Phibro Animal Health
PAHC
$1.53B
| $1.53M | ﹤0.01% |
119,593
+49,597
| +71% | +$703K |
|
3743
PUT
Hawaiian Electric Industries
HE
$1.97B
| $1.52M | ﹤0.01% |
+123,800
| New | +$3.01M |
|
3744
CALL
Williams Companies
WMB
$90.2B
| $1.52M | ﹤0.01% |
45,200
-71,000
| -61% | -$2.42M |
|
|
AMED
3745
PUT
DELISTED
Amedisys
AMED
| $1.52M | ﹤0.01% |
16,300
-73,600
| -82% | -$6.8M |
|
|
SVM
3746
Silvercorp Metals
SVM
$2.82B
| $1.52M | ﹤0.01% |
649,839
-759,683
| -54% | -$2.06M |
|
3747
Simmons First National
SFNC
$3.28B
| $1.52M | ﹤0.01% |
89,559
+66,647
| +291% | +$1.2M |
|
3748
CALL
Sea Limited
SE
$73.1B
| $1.52M | ﹤0.01% |
34,500
-2,200
| -6% | -$108K |
|
|
FUSN
3749
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.51M | ﹤0.01% |
582,129
+247,552
| +74% | +$794K |
|
3750
Sierra Bancorp
BSRR
$516M
| $1.51M | ﹤0.01% |
79,756
+60,217
| +308% | +$1.18M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.